(Q44663778)

5 December 2017

title

Mycophenolate mofetil limits renal damage and prolongs life in murine lupus autoimmune disease (English)

1 reference

5 December 2017

6

1 reference

5 December 2017

D Corna

1

1 reference

5 December 2017

M Morigi

2

1 reference

5 December 2017

D Facchinetti

3

1 reference

5 December 2017

T Bertani

4

1 reference

5 December 2017

C Zoja

5

1 reference

5 December 2017

language of work or name

English

0 references

publication date

1 May 1997

1 reference

5 December 2017

1 reference

5 December 2017

volume

51

1 reference

5 December 2017

issue

5

1 reference

5 December 2017

page(s)

1583-1589

1 reference

https://scigraph.springernature.com/pub.10.1038/ki.1997.217

5 December 2017

exact match

0 references

cites work

Etiopathogenesis of Murine SLE1

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.217

7 January 2021

Apoptosis, nucleosomes, and nephritis in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.217

7 January 2021

Towards understanding the pathogenesis of SLE

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.217

7 January 2021

Anti-DNA antibodies can bind to the glomerulus via two distinct mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.217

7 January 2021

Cross-reactivity of monoclonal anti-DNA antibodies with heparan sulfate is mediated via bound DNA/histone complexes

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.217

7 January 2021

Glomerular immune deposits in murine lupus models may contain histones

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.217

7 January 2021

Therapeutic studies in NZB/W mice. III. Relationship between renal status and efficacy of immunosuppressive drug therapy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.217

7 January 2021

CYCLOPHOSPHAMIDE TREATMENT OF RENAL DISEASE IN (NZB × NZW) F1 HYBRID MICE

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.217

7 January 2021

Immunosuppressive drug therapy in lupus nephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.217

7 January 2021

Lymphocyte-selective antiproliferative and immunosuppressive effects of mycophenolic acid in mice

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.217

7 January 2021

RS-61443--a phase I clinical trial and pilot rescue study

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.217

7 January 2021

Minimization of variation in the response to different proteins of the Coomassie blue G dye-binding assay for protein

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.217

7 January 2021

Some statistical methods useful in circulation research.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.217

7 January 2021

Treatment of murine lupus nephritis with cyclophosphamide or total lymphoid irradiation

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.217

7 January 2021

Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.217

7 January 2021

The effect of cyclosporin A on early and late stages of experimental lupus

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.217

7 January 2021

Effect of a novel immunosuppressant, FK506, on spontaneous lupus nephritis in MRL/MpJ-lpr/lpr mice

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.217

7 January 2021

Experimental therapy of systemic lupus erythematosus: the treatment of NZB/W mice with mouse soluble interferon-gamma receptor inhibits the onset of glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.217

7 January 2021

Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.217

7 January 2021

F(ab')2 anti-CD4 and intact anti-CD4 monoclonal antibodies inhibit the accumulation of CD4+ T cells, CD8+ T cells, and B cells in the kidneys of lupus-prone NZB/NZW mice

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.217

7 January 2021

https://api.crossref.org/works/10.1038%2FKI.1997.217

1 reference

7 January 2021

Abrogation of macrophage-dependent injury in experimental glomerulonephritis in the rabbit. Use of an antimacrophage serum

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.217

7 January 2021

CYCLOPHOSPHAMIDE TREATMENT OF KIDNEY DISEASE IN (NZB X NZW) F1 MICE

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.217

7 January 2021

Therapeutic studies in NZB/W mice. I. Synergy of azathioprine, cyclophosphamide and methylprednisolone in combination

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.217

7 January 2021

Comparison of therapeutic and immunosuppressive effects of azathioprine, prednisolone and combined therapy in NZP-NZW mice

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.217

7 January 2021

Effect of FK-506, a novel immunosuppressive drug on murine systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.217

7 January 2021

Identifiers

DOI

10.1038/KI.1997.217

1 reference

5 December 2017

1 reference